Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Journal Article

Al-Sawaf, Othman, Lilienweiss, Esther, Bahlo, Jasmin, Robrecht, Sandra, Fink, Anna-Maria, Patz, Michaela, Tandon, Maneesh, Jiang, Yanwen, Schary, William, Ritgen, Matthias, Tausch, Eugen, Stilgenbauer, Stephan, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael and Kreuzer, Karl-Anton (2020). High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia. Blood, 135 (11). S. 866 - 871. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furstenau, Moritz, Thus, Yvonne, Robrecht, Sandra, Mellink, Clemens, Van der Kevie-Kersemaekers, Anne-Marie, Dubois, Julie M. N., Von Tresckow, Julia, Patz, Michaela, Gregor, Michael, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Levin, Mark-David, Da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian Bjorn, Illmer, Thomas, Schoettker, Bjorn, Janssens, Ann, Christiansen, Ilse, Baumann, Michael, Noesslinger, Thomas, Regelink, Josien, Dompeling, Ellen C., Lindstroem, Vesa, Juliusson, Gunnar, Widmer, Anouk, Goede, Jeroen Simon, Goldschmidt, Neta, Simon, Florian, De Silva, Nisha, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Ritgen, Matthias, Brueggemann, Monika, Tausch, Eugen, Stilgenbauer, Stephan, Eldering, Eric, Niemann, Carsten Utoft, Hallek, Michael, Eichhorst, Barbara, Kreuzer, Karl-Anton and Kater, Arnon P. (2022). High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without TP53 Aberrations Treated with Venetoclax-Based Time-Limited Combinations. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Huelsemann, Malte F., Patz, Michaela, Beckmann, Laura, Brinkmann, Kerstin, Otto, Teresa, Fandrey, Joachim, Becker, Hans Jiro, Theurich, Sebastian, von Bergwelt-Baildon, Michael S., Pallasch, Christian P., Zahedi, Rene P., Kashkar, Hamid, Reinhardt, Christian, Hallek, Michael, Wendtner, Clemens-Martin and Frenzel, Lukas P. (2014). p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Patz, Michaela, Pentok, Barbara, Cremer, Kathrin, Linnartz, Stefanie, Lilienweiss, Esther, Kleinert, Fanni, Hallek, Michael and Kreuzer, Karl-Anton (2017). Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL) via an 8 color flow cytometry panel comprising the signature gene ROR1. Leuk. Lymphoma, 58. S. 93 - 95. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Patz, Michaela, Pentok, Barbara, Cremer, Kathrin, Linnartz, Stefanie, Lilienweiss, Esther, Kleinert, Fanni, Hallek, Michael and Kreuzer, Karl-Anton (2016). ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Schwamb, Janine, Feldhaus, Valeska, Baumann, Michael, Patz, Michaela, Brodesser, Susanne, Brinker, Reinhild, Claasen, Julia, Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Hallek, Michael, Wendtner, Clemens-Martin and Frenzel, Lukas P. (2012). B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood, 120 (19). S. 3978 - 3986. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Thesis

Patz, Michaela (2009). Beteiligung des Transmembranrezeptors CD5 und der durch miRNA modulierten Expression des Proto-Onkogens PLAG1 an der Pathogenese der Chronischen Lymphatischen Leukämie. PhD thesis, Universität zu Köln.

This list was generated on Thu Mar 28 20:03:37 2024 CET.